Litigation
Amarin Describes USITC Decision Not to Investigate Omega-3 Products as Arbitrary and Capricious
LitigationAmarin Describes USITC Decision Not to Investigate Omega-3 Products as Arbitrary and CapriciousAmarin Describes USITC Decision Not to Investigate Omega-3 Products as Arbitrary and Capricious
Amarin Pharma argued the U.S. International Trade Commission should have investigated a complaint brought against certain synthetically produced, omega-3 products.
Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.